Table 2 Selection of Renal Replacement Therapy, Platelet Counts, Perioperative management and bleeding complications in Patients with MYH9-RD
Age, sex | Platelets (× 109/L) | Dialysis | Perioperative care | Bleeding episodes, Comments | Ref |
|---|---|---|---|---|---|
33, M | 4 | PD → HD → RTx | Plt transfusion with a target of 100 × 109 for 7 days during RTx | Anti-platelet antibody positive | [4] |
8, M | 5 | HD → RTx | Plt transfusion with a target of 100 × 109 for 7 days during RTx | Bleeding of the oral cavity | [4] |
22, M | 5 | PD → RTx | Transfusion of 30 units of platelet for RTx | NS | [16] |
30, M | 7 | HD | NS | Recurrent bleeding incidents from venous access during HD. Plt transfusion every other week. TPO-RA used | [6] |
45, F | 8 | HD | NS | Nose bleeds | [7] |
66, F | 8 | dialysis | NS | Nose bleeds, bruise | [5] |
23, M |  < 10 | RTx | Plt transfusion with a target of 100 × 109 | NS | [21] |
25, M | 10 | HD | NS | Nose bleeds, mucosal bleedings. No heparin used during HD | [8] |
24, M | 18–46 | dialysis | NS | Two severe nose bleeds | [9] |
11, M | 25 | RTx | Plt transfusion with a target of 100 × 109 for 7 days during RTx | Hematoma after renal biopsy | [4] |
22, M | 28–31 | HD → RTx | Thromboelastometry used without transfusion | NS | [10] |
11, M | 36 | RTx | Plt transfusion with a target of 100 × 109 for 7 days during RTx | NS | [4] |
70, F | 45 | HD | NS | Use of heparin during HD | [11] |
13, M | 45 | HD | NS | Plt transfusion reaction present | [12] |
34, M | 46 | HD | Plt transfusion for AVF creation | Nose bleeds. No heparin used during HD | [13] |
16, M | 70 | PD → HD → RTx | Plts 115 × 109 after transfusion for RTx | NS | [14] |
10, M | NS | HD | NS | Nose bleeds | [17] |
27, M | NS | PD | NS | NS | [18] |
20, M | NS | HD → RTx | Plt transfusion to maintain a minimum of 50 × 109 | Postoperative intra-abdominal hematoma, duodenal ulcer | [19] |
7, F | NS | HD → PD | Plt transfusion before renal biopsy | NS | [12] |
17, F | NS | RTx | Plt transfusion to maintain a minimum of 50 × 109 | Postoperative intracapsular hemorrhage, postoperative intra-abdominal hematoma | [21] |
35, M | NS | HD → PD → HD | NS | Nose bleeds, prolonged bleeding after the PD catheter insertion, multiple bleeding into the PD dialysate | [20] |